These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9648491)

  • 1. [Hypogonadism and osteoporosis].
    Natsume H; Nakamura H
    Nihon Rinsho; 1998 Jun; 56(6):1613-7. PubMed ID: 9648491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of osteoporosis in male hypogonadism].
    Tsukamoto T; Itoh N
    Clin Calcium; 2006 Mar; 16(3):481-5. PubMed ID: 16508132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
    Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
    N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone and Men's Health. Androgen replacement therapy and bone metabolism].
    Ogawa S
    Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoestrogenism in young women and its influence on bone mass density.
    Meczekalski B; Podfigurna-Stopa A; Genazzani AR
    Gynecol Endocrinol; 2010 Sep; 26(9):652-7. PubMed ID: 20504098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and sex hormone status in intellectually disabled women on progestin-induced amenorrhea.
    Arvio M; Kilpinen-Loisa P; Tiitinen A; Huovinen K; Mäkitie O
    Acta Obstet Gynecol Scand; 2009; 88(4):428-33. PubMed ID: 19330573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive osteoporosis during androgen deprivation therapy for prostate cancer.
    Daniell HW; Dunn SR; Ferguson DW; Lomas G; Niazi Z; Stratte PT
    J Urol; 2000 Jan; 163(1):181-6. PubMed ID: 10604342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoporosis caused by pediatric diseases].
    Naiki Y; Tanaka T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():572-6. PubMed ID: 16279703
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
    Horner KC
    Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy.
    Yaturu S; DjeDjos S; Alferos G; Deprisco C
    Prostate Cancer Prostatic Dis; 2006; 9(1):35-8. PubMed ID: 16276350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone has a sexually dimorphic response to aromatase deficiency.
    Oz OK; Zerwekh JE; Fisher C; Graves K; Nanu L; Millsaps R; Simpson ER
    J Bone Miner Res; 2000 Mar; 15(3):507-14. PubMed ID: 10750565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypogonadism and osteoporosis].
    Chaki O
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():426-34. PubMed ID: 11979939
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteoporosis in Klinefelter's syndrome.
    Ferlin A; Schipilliti M; Di Mambro A; Vinanzi C; Foresta C
    Mol Hum Reprod; 2010 Jun; 16(6):402-10. PubMed ID: 20348548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy Insight: osteoporosis during hormone therapy for prostate cancer.
    Smith MR
    Nat Clin Pract Urol; 2005 Dec; 2(12):608-15; quiz 628. PubMed ID: 16474548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.
    Smith EP; Boyd J; Frank GR; Takahashi H; Cohen RM; Specker B; Williams TC; Lubahn DB; Korach KS
    N Engl J Med; 1994 Oct; 331(16):1056-61. PubMed ID: 8090165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer treatment-induced bone loss.
    Adler RA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
    Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
    Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.